Dr. Lindsay Rosenwald is part of the Republican Jewish Coalition as a member of the Board of Directors. The coalition officially recognizes him by displaying a short biography on their website, www.rjchq.org. It informs visitors of his current position as the senior managing director at the biotechnology financing company. Dr. Lindsay Rosenwald co-founded the company, and he continues to contribute to the biotechnology field by providing financing in the form of private equity, hedge funds, and venture capital.
At www.muckety.com, Dr. Lindsay Rosenwald’s relationship to the Republican Jewish Coalition is visually illustrated in a diagram-like map.
Dr. Lindsay Rosenwald has a profile on Wellness.com that displays his education, current practice, and services offered. He is a graduate of Temple University Medical School, and he presently works as a general practitioner in New York City. As a general practitioner, Dr. Lindsay Rosenwald provides an array of services which include bone density testing, immunizations, physical examinations, and stress reduction plans.
The NyICECATS have recognized Dr. Lindsay Rosenwald on multiple occasions as an exceptional member of the organization’s adult team. The NyICECATS is a Jewish Orthodox youth hockey organization that has branched out to adults. At both the third and fourth annual Captain’s Dinner, held on March 12th at Le Marais in New York City, Dr. Lindsay Rosenwald was honored and presented with gifts by Neil Herskowitz, who is the Director of Manhattan Pharmaceutical, Inc. The gifts of team included a Bauers 190. As the night went on, Dr. Lindsay Rosenwald made an announcement that he was committed to playing hockey at the Piers for 25 more years. The dinner concluded with the “Golden Balls” award ceremony.
A search for Dr. Lindsay Rosenwald in the Huffington Post’s FundRace of 2008 displays his donation to the McCain Victory Committee of $61,800.
Dr. Lindsay Rosenwald is the one known till today by many people related to Biotechnology field due to his sacrifice and efforts to bring this area to such heights that it takes lots of time to one to begin. It is the Rosenwald who started to implement such companies which are know very successful and very popular. Out of these companies some of them are also related to financial investments. These are also the companies which are interlinked with the fields like Biotechnology and Life Sciences.
Dr. Lindsay Rosenwald can also be known to start companies which were the inventories to the new drugs that help the human life a lot by curing the diseases that affect human body by making them weak. Cougar Biotechnology and Polarx Biopharmaceuticals are the two most popularly known companies under the foundation of Rosenwald. These two companies invented two new drugs in addition to the older ones. Though these drugs are being developed by the companies under Rosenwald’s guidance they are being allowed to enter the market after few medical tests. Drugs are the one which are known scientifically as life Savers.
All the inventions and developments of the drugs are done by highly qualified people related to various fields of Biotechnology under scientific research. It can be said that the team is grouped in accordance to the experts who are highly skilled with the practical and theoretical knowledge. The formulation of the drug and its manufacturing are done in a process like technology transfer, pharmacology and toxicology aspects of the drug, clinical development, regulatory, marketing, etc. The sacrifices of these team members are valued with the success selling of their products in the market.
It is Dr. Lindsay Rosenwald was a person by whom many new young Biotechnologists where inspired and laid new ways to further success. Drugs under Rosenwald’s foundation helped to cure more deadly diseases which can be thought as the one having no treatment. Rosenwald was the one with two invaluable features which were both as per financial and physician analysts.
Dr. Lindsay Rosenwald, performs projects with that assembly of organizations which is mostly involving investment money managing, asset control, plus direct investing and venture capital in the life-science and biotechnological business. He uses a mixture of U.S. based and also foreign hedge funds along with private equity for the purpose of managing their investor assets. He is a broker dealer who has FINRA membership and has specialized in helping public and private biotechnology organizations in the initial stage in supervising private and public placement offerings. His organization is a highly focused group whose effort is to take a comprehensive profit in both private and public companies. This includes troubled turn-around and start-up businesses. It is both a health care investment bank and an worldwide run pharmaceutical item improvement firm. Supplementary to that Dr. Lindsay Rosenwald has a membership with the Managing Member of Orion Biomedical Fund, LP and the Orion Biomedical Offshore Fund, LP. Both of these organizations are managing in Financing. For more than 20 years, Dr. Lindsay Rosenwald has collaborated as a Wall Street capitalist in biotechnology. He has originated and re-capitalized many private and public life-sciences and biotechnology establishments. The businesses has so far invented three different chemical compounds that have been accepted by the FDA and they presently have a considerable number of products that are even still undergoing clinical trials. One of these is a portfolio company known as PolaRx BioPharmaceuticals, Inc., has been granted a final marketing approval for a leukemia compound recognized as arsenic trioxide. This was concluded only 30 months, an industry record, after the treatment of the very first testees was processed in a corporate clinical trial. 5 Other than Cougar Biotechnology, Dr. Lindsay Rosenwald has in addition taken it upon himself to also support or create such companies as Bradley Pharmaceuticals, Inc., Repligen Corporation, Avigen, Inc., Cardiome Pharma Corp., Neose Technologies Inc., Biocryst Pharmaceuticals, Inc, Cypress Bioscience, Inc., Genta, Inc, Discovery Laboratories, Inc., Indevus Pharmaceuticals, Inc., Keryx Biopharmaceuticals, Inc., Cell Therapeutics, Inc., and Hudson Health Sciences, Inc. As far as his educational history, Dr. Lindsay Rosenwald was a graduate of Abington High School, in the southeast vicinity of Pennsylvania, back in 1973. He then went on to graduate Beta Gamma Sigma as well as a degree in Finance and Economy from Pennsylvania State University in 1977. Shortly after, he attained employment as a management consultant (working independently), performing for various health care establishments during the years 1977 to 1979 and then entering himself into the Temple University School of Medicine. He graduated from Temple in 1983 and soon afterward was awarded an internship at the Abington Medical Hospital, continuing in the private health system until the year 1986. Dr. Lindsay Rosenwald then moved on to Wall Street in order to syndicate his financial and medical skills and function as a doctor/financial analyst.
Dr. Lindsay Rosenwald reputed himself as a corporate finance managing director for D.H. Blair & Company, in the year of 1988. This was a privately owned investment based business. There, he was the leader of a team of three physician-financiers that sought through the medical community for any new and profitable break-through that could make use of private investment. They located various schools of medicine, universities, hospitals, drug companies, study groups, and scientific firms. He has worked within the biotechnology and bioresearch disciplines. Dr. Rosenwald serves on the Columbia-Presbyterian Health Sciences Advisory Counsel and in the 2002 article edition of Genetic Engineering News he was ranked number one in the list of 100 Molecular Millionaires with a worth of $617,721,671. Dr. Lindsay Rosenwald operated on the Keryx Biopharmaceutical, Inc board of directors from 2002 to 2006. He quit in order to contribute additional time performing in the biotechnology market. Cougar Biotechnology, purchased by Johnson & Johnson in 2009, is another business that was first founded by Dr. Rosenwald and was originated completely on abiraterone acetate. Abiraterone Acetate, even though it had not yet attained phase III in clinical testing trials, was showing so much potential in the therapy and management for prostate cancer that Johnson & Johnson offered a short-term unification bid and procurement for the Cougar Biotechnology corporation for $1 billion. Dr. Lindsay Rosenwald, apart from the scores of ventures which have imparted financing and resources to portfolio companies, has also began the Rosenwald Foundation. This is a nonprofit outfit that has been triumphant in offering millions of dollars in aid of many medical and scientific instruction institutions.
